Absolute Markets Insights has announced a statistical data to its extensive repository titled Antibiotic Resistance market. The study comprises of different segments and sub-segments such as type, size, applications, and end-users. One of the many distinctive features of the report is it provides an analytical study of the global Antibiotic Resistance market based on various growth influencing factors. Primary and secondary research techniques have also been used by analysts of the report to study the market. The study also uses information on widespread global regions such as North America, Latin America, Europe, Asia-Pacific, Africa, and India in order to get a better understanding of the competitive landscape. The research report extensively focuses on market size, pricing structures, and shares. The current development patterns of various successful industries have also been mentioned in order to understand effective business strategies.
Moreover, the report also offers the entire demand-supply chain of a Antibiotic Resistance market to comprehend the demanding structure of the Antibiotic Resistance sector. In this effective and informative report, top-notch industries have been enlisted in order to provide a detailed analysis of successful strategies implemented by various companies. To get a stronger and effective business outlook different internal and external factor are mentioned. These can be attributed as market restraints and propellers. Additionally, the report also offers insightful data to formulate best strategies for both established key players as well as for new market entrants. Furthermore, the study discusses the challenges and risks experienced by several sellers as well as buyers. Various applicable sales strategies are also included to discover the global opportunities shaping the global Antibiotic Resistance market.
For more information about this report visit: https://www.industryglobalnews24.com/global-antibiotic-resistance-market-to-grow-at-4-cagr-during-20212029
Key Findings of the Report:
The global antibiotic resistance market was valued at US$ 8417.36 Mn in 2020 growing at a CAGR of 4% over the forecast period (2021 – 2030).
The carbapenem-resistant enterobacteriaceae (CRE) category in the global antibiotic resistance market held the larger market share in 2020. Carbapenem-resistant enterobacteriaceae (CRE) are a family of bacteria that are very difficult to treat due to their highly resistant nature towards antibiotics. They have a reputation of adapting to different types of antibiotic treatments and develop resistance towards them.
The complicated urinary tract infections (cUTI) category in the global antibiotic resistance market held the larger share in 2020. Urinary tract infections (UTIs) are considered to be one of the most common types of infections. According to studies, at least one in two women and one in 10 men experience UTI in their life period.
Antifolates segment occupied the largest market share in the global antibiotic resistance market in 2020. Antifolate drugs are helpful in the treatment of communicable and infectious diseases such as malaria. Many bacteria and viruses that have developed antibiotic resistance spread diseases similar to malaria, such as dengue and other mosquito-borne diseases.
In 2020, North America dominated the global antibiotic resistance market. Availability of advanced medical sector, increasing prevalence of infectious diseases, presence of major market players, numerous drug launches in the market, and rising growth in the pharmaceutical sector amongst other factors have contributed towards the region’s highest share. Infectious Diseases Society of America (IDSA) has approved the use of many new drugs that are expected to offer successful treatment against bacteria and viruses that have developed antibiotic resistance.
Vendor Profiling: Antibiotic Resistance Market: Allergan Pharma Co., GlaxoSmithKline PLC., Johnson & Johnson Services Inc., MELINTA THERAPEUTICS - THE ANTIBIOTICS COMPANY, Merck & Co. Inc., Mylan N.V., Nabriva Therapeutics PLC, Otsuka Novel Products GmbH, Pfizer Inc., and Sandoz AG amongst others.
Global Antibiotic Resistance Market: Research Scope
By Resistant Bacteria Type
Clostridioides difficile (C. difficile)
Carbapenem-resistant Enterobacteriaceae (CRE)
Streptococcus pneumoniae (S. pneumoniae)
Vancomycin-resistant Enterococci (VRE)
Mycobacterium Tuberculosis (TB)
Neisseria gonorrhoeae (N. gonorrhoeae)
By Disease Indication
Complicated Urinary Tract Infections (cUTI)
Complicated Intra-Abdominal Infections (cIAI)
Community-Acquired Bacterial Pneumonia (CABP)
Acute Skin and Skin Structure Infections (ABSSSI)
Multidrug-Resistant (MDR) and Pulmonary Extensively Drug Resistant (XDR) Tuberculosis (TB) (MDR-TB and XDR-TB)
Clostridium Difficile (C. difficile) Infections
By Drug Class
By Route of Administration
By End Use
Middle East and Africa
Company: Absolute Markets Insights
Email id: [email protected]
Contact Name: Shreyas Tanna